Recently, several mutations in SHP-2 were found in children with diverse myeloproliferative disorders or malignant leukemia such as juvenile myelomonocytic leukemia (JMML), myelodysplastic syndrome, B cell acute lymphocytic leukemia, and acute myeloid leukemia20–23. This evidence concerns the gene PTPN11 and myeloproliferative disorder.